ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,149.27
0.79%
Dow Jones
43,951.11
1.25%
Gold vs US Dollar
2,669.635
0.65%
Brent Oil
73.935
1.50%
Bitcoin
98,643.51
4.54%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Sanofi (SAN) Share Price

SAN Sanofi

90.87
0.07 (0.08%)
21 Nov 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Sanofi EU:SAN Euronext Ordinary Share FR0000120578 
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.07 0.08 90.87 90.65 91.30 91.04 90.21 90.44 1,332,630 16:40:00   
 Type  Size  Price  Time  Units 
  5,989 90.87 16:35:26 EUR
 
Recent News
DateTimeSource
HeadlineMore SAN News
20/11/202413:11UKREGSanofi: Information concerning the total number of voting rights and shares - October 2024
20/11/202413:11UKREGSanofi: Informations relatives au nombre de droits de vote et d'actions - Octobre 2024
15/11/202406:00UKREGCommuniqué de presse : La FDA a accepté l’examen de la sBLA pour le Dupixent dans le traitement de l’urticaire chronique spontanée
15/11/202406:00GLOBEPress Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
15/11/202406:00UKREGPress Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
14/11/202416:42GLOBEPress Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma
14/11/202416:42UKREGPress Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
05/09/202407:18PBBSantanders 10.3/8%235
22/11/201311:46PBBSABMiller PLC1
12/01/201007:59PBBSanatana - Canadian Diamond Hunting121
Data Downloads for SAN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Sanofi Articles

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Level 2 Lite

1 year 40%, 2 years 50% and *3 years 60%
EU Flag

*Across 3 years £2132.64 only £853.06